Authors:
BELL IM
ERB JM
FREIDINGER RM
GALLICCHIO SN
GUARE JP
GUIDOTTI MT
HALPIN RA
HOBBS DW
HOMNICK CF
KUO MS
LIS EV
MATHRE DJ
MICHELSON SR
PAWLUCZYK JM
PETTIBONE DJ
REISS DR
VICKERS S
WILLIAMS PD
WOYDEN CJ
Citation: Im. Bell et al., DEVELOPMENT OF ORALLY-ACTIVE OXYTOCIN ANTAGONISTS - STUDIES ON DIN-3-YLMETHYL)PIPERIDIN-4-YLOXY]-2-METHOXYBENZOYL IPERIDIN-4-YL)-1,4-DIHYDROBENZ[D][1,3]OXAZIN-2-ONE (L-372,662) AND RELATED PYRIDINES, Journal of medicinal chemistry, 41(12), 1998, pp. 2146-2163
Authors:
WILLIAMS PD
CLINESCHMIDT BV
ERB JM
FREIDINGER RM
GUIDOTTI MT
LIS EV
PAWLUCZYK JM
PETTIBONE DJ
REISS DR
VEBER DF
WOYDEN CJ
Citation: Pd. Williams et al., ENZOYL]PIPERIDIN-4-YL)-4H-3,1-BENZOXAZIN-2(1H)-ONE (L-371,257) - A NEW, ORALLY BIOAVAILABLE, NONPEPTIDE OXYTOCIN ANTAGONIST, Journal of medicinal chemistry, 38(23), 1995, pp. 4634-4636
Authors:
WILLIAMS PD
ANDERSON PS
BALL RG
BOCK MG
CARROLL L
CHIU SHL
CLINESCHMIDT BV
CULBERSON JC
ERB JM
EVANS BE
FITZPATRICK SL
FREIDINGER RM
KAUFMAN MJ
LUNDELL GF
MURPHY JS
PAWLUCZYK JM
PERLOW DS
PETTIBONE DJ
PITZENBERGER SM
THOMPSON KL
VEBER DF
Citation: Pd. Williams et al., )-YL)METHYL)SULFONYL)-4-(2-METHYLPHENYL)PIPERAZINE (L-368,899) - AN ORALLY BIOAVAILABLE, NONPEPTIDE OXYTOCIN ANTAGONIST WITH POTENTIAL UTILITY FOR MANAGING PRETERM LABOR, Journal of medicinal chemistry, 37(5), 1994, pp. 565-571
Authors:
EVANS BE
LUNDELL GF
GILBERT KF
BOCK MG
RITTLE KE
CARROLL LA
WILLIAMS PD
PAWLUCZYK JM
LEIGHTON JL
YOUNG MB
ERB JM
HOBBS DW
GOULD NP
DIPARDO RM
HOFFMAN JB
PERLOW DS
WHITTER WL
VEBER DF
PETTIBONE DJ
CLINESCHMIDT BV
ANDERSON PS
FREIDINGER RM
Citation: Be. Evans et al., NANOMOLAR-AFFINITY, NONPEPTIDE OXYTOCIN RECEPTOR ANTAGONISTS, Journal of medicinal chemistry, 36(25), 1993, pp. 3993-4005